The Patent Finder
US

Nanopatterned Medical Device with Enhanced Cellular Interaction

US 10,245,421 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 27, 2031 · High confidence

Filed Apr 27, 2011 as application 13/095,489 · Granted Apr 2, 2019
Base term plus 1215 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2011 2031
Clock starts
Apr 27, 2011
Term ends
Apr 27, 2031
Granted
Apr 2, 2019
base term fee events Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,215
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,029,082, US 10,029,083, US 10,029,084, US 9,522,262, US 9,522,263, US 9,526,883, US 9,545,507, US 9,550,053.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
76
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1215 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 27, 2011, when this application, 13/095,489, was filedApr 27, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1215 days, USPTO patent term adjustment recordAug 24, 2034High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,029,082, US 10,029,083, US 10,029,084, US 9,522,262, US 9,522,263, US 9,526,883, US 9,545,507, US 9,550,053)capped to Apr 27, 2031High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 27, 2031High confidence

Partial family

US 8,696,637Lapsed on the fee record
Apr 2026
Apr 2026
US 10,245,421this patent
Apr 2031
Apr 2031
Application PCT/IB2011/051860PCT application
no patent term
no patent term
Application PCT/IB2011/051861PCT application
no patent term
no patent term
Application PCT/IB2011/051862PCT application
no patent term
no patent term
Application PCT/IB2011/051863PCT application
no patent term
no patent term
Application PCT/IB2011/051864PCT application
no patent term
no patent term
US 8,636,696Lapsed on the fee record
Jan 2026
Jan 2026
8 of 76 applications in this family shown, earliest filings first. Partial: 11 of the 76 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 11, 2011
Reel 26570, frame 28
Ross, Russell FrederickKimberly-Clark Worldwide, Inc.Assignment of Assignor's Interest
Feb 3, 2015
Reel 34880, frame 634
Kimberly-Clark Worldwide, Inc.Kimberly-Clark Worldwide, Inc.Name Change
Sep 18, 2018
Reel 46899, frame 689
Kimberly-Clark Worldwide, Inc.Sorrento Therapeutics, Inc.Assignment of Assignor's Interest
Nov 7, 2018
Reel 47446, frame 335
Sorrento Therapeutics, Inc.; TNK Therapeutics, Inc.; Concortis Biosystems, Corp.; Ark Animal Health, Inc.; Scintilla Pharmaceuticals, Inc.Oaktree Fund Administration, LLCSecurity Interest
Jul 31, 2020
Reel 53368, frame 577
Oaktree Fund Administration, LLCSorrento Therapeutics, Inc.; TNK Therapeutics, Inc.; Concortis Biosystems, Corp.; Ark Animal Health, Inc.; Scintilla Pharmaceuticals, Inc.Release of Security Interest
Jul 31, 2020
reel/frame not recorded
Oaktree Fund Administration, LLCSorrento Therapeutics, Inc.Release of Security Interest
Jul 31, 2020
reel/frame not recorded
Oaktree Fund Administration, LLCTNK Therapeutics, Inc.Release of Security Interest
Jul 31, 2020
reel/frame not recorded
Oaktree Fund Administration, LLCConcortis Biosystems, Corp.Release of Security Interest
Jul 31, 2020
reel/frame not recorded
Oaktree Fund Administration, LLCArk Animal Health, Inc.Release of Security Interest
Jul 31, 2020
reel/frame not recorded
Oaktree Fund Administration, LLCScintilla Pharmaceuticals, Inc.Release of Security Interest
Apr 6, 2023
Reel 63283, frame 63
Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc.JMB Capital Partners Lending, LLCSecurity Interest
Jul 31, 2023
Reel 64441, frame 575
Sorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc.Scilex Holding CompanySecurity Interest
Aug 11, 2023
Reel 64571, frame 848
JMB Capital Partners Lending, LLCSorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc.Release of Security Interest
Aug 11, 2023
reel/frame not recorded
JMB Capital Partners Lending, LLCSorrento Therapeutics, Inc.Release of Security Interest
Aug 11, 2023
reel/frame not recorded
JMB Capital Partners Lending, LLCScintilla Pharmaceuticals, Inc.Release of Security Interest
Sep 21, 2023
Reel 65017, frame 844
Scilex Holding CompanySorrento Therapeutics, Inc.; Scintilla Pharmaceuticals, Inc.Termination and Release of Security Interest in Intellectual Property
Sep 21, 2023
reel/frame not recorded
Scilex Holding CompanySorrento Therapeutics, Inc.Termination and Release of Security Interest in Intellectual Property
Sep 21, 2023
reel/frame not recorded
Scilex Holding CompanyScintilla Pharmaceuticals, Inc.Termination and Release of Security Interest in Intellectual Property

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited